Analysis: China’s Pharma Sector Pivots to ‘First-in-Class’ Drugs Amid Innovation Push

With more drugs in clinical trials than any other country, Chinese drugmakers are now shifting focus to the high-risk, high-reward field of creating truly original medicines to move beyond an era of imitation and intense competition

Raccontata dacaixinglobal.com